Atopaxar
Atopaxar (E5555) is a reversible protease-activated receptor-1 (PAR-1) antagonist that inhibits thrombin-mediated platelet aggregation. It has been studied in preclinical and clinical research for the potential management of acute coronary syndrome and coronary artery disease.
Product Specifications
CAS Number
751475-53-3
Product Name Alternative
Inhibit, platelets, PAR-1, ER-172594-00, Inhibitor, atherothrombotic, Atopaxar, E 5555, E5555, E-5555, receptor-1, receptor, signaling, Protease Activated Receptor (PAR), protease-activated, Protease-Activated Receptor (PAR), Proteaseactivated Receptor, ProteaseactivatedReceptor, thrombin, Thrombin receptors
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
97.07% (May vary between batches)
Solubility
DMSO:30 mg/mL (56.86 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.79 mM)
Smiles
CCOc1cc2CN (CC (=O) c3cc (N4CCOCC4) c (OC) c (c3) C (C) (C) C) C (=N) c2c (F) c1OCC
Molecular Formula
C29H38FN3O5
Molecular Weight
527.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-18059R-APC-Cy5.5 100 µL
HMX1 Polyclonal Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 
